As the journal’s newest team of editors begins its 5-year term, we look to the past to appreciate and preserve certain traditions that have led to the success of HEPATOLOGY, but we also look to the future to ensure that the journal will evolve as needed to continue to support the advancement

of the science and practice of Hepatology in the most effective ways. For the next 5 years, the journal will be based in New Haven, CT. This is of historical significance, because Yale University was home to Gerald Klatskin, one of the first hepatologists, one of the founding members of the AASLD, and one of four of the society’s presidents who have come from here. However, we also are continuing the newer tradition of assembling the most outstanding

MI-503 mw possible board of Associate Editors and Section Editors, without regard to geographical location. This includes James Boyer and Roberto Groszmann (both from Yale) as Senior Associate Editors, plus the following group of Associate Editors: Pifithrin-�� price Frank Anania (Emory University), Jorge Bezerra (Cincinnati Children’s Hospital), James Dziura (Yale), Guadalupe Garcia-Tsao (Yale), Stephen Harrison (Brooke Army Medical Center), Donald Jensen (University of Chicago), Brett Lindenbach (Yale), Jacquelyn Maher (University of California San Francisco), Wajahat Mehal (Yale), Lola Reid (University of North Carolina Chapel Hill), Mario Strazzabosco (University of Milan-Bicocca, Italy), Norah Terrault (University of California San Francisco), Snorri Thorgeirsson (National Cancer medchemexpress Institute), and Michael Trauner (Medical University of Vienna).

Section Editors include Simona Jakab, Yasuko Iwakiri, and Tamar Taddei (each from Yale), and Victor Navarro (Thomas Jefferson University Hospitals). Of course, the Editors rely critically on the Editorial Board to ensure that the journal receives the most informed and critical reviews of manuscripts, and in recognition of this, we are expanding the size of our Editorial Board, but coupling this with increased responsibility for the frequency and speed of reviews that each board member will provide. The average time from submission to decision of new manuscripts has decreased to approximately 3 weeks, which is impressive, but we intend to shorten this further with the help of our new board. We also will continue to rely on the journal’s editorial office, including our managing editor Greg Bologna, assisted by Ann Haran, Kareytis Martinez, Karina Bustillo, and Tazeen Shirazi in our central office in Alexandria, VA, and Dana Lombardi in New Haven, CT, who together provide the infrastructure that has permitted HEPATOLOGY to be the leading liver journal.